No Data
Conduit Pharmaceuticals Faces Nasdaq Delisting, Plans Stock Split
Conduit Pharmaceuticals Enters Agreement With Sarborg To Leverage AI And Cybernetics Platform To Evaluate Key Deliverables Across Multiple Areas Of Operations
Conduit Pharmaceuticals to Enter Agreement With SARBOR
Express News | Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics
Conduit Pharmaceuticals Files to Sell 75M Shares of Common Stock for Holders
12 Health Care Stocks Moving In Thursday's Pre-Market Session
